We are live on ! Find out more
ASMB icon

Assembly Biosciences

37 hedge funds and large institutions have $30.4M invested in Assembly Biosciences in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

6% more funds holding

Funds holding: 3537 (+2)

7.75% less ownership

Funds ownership: 50.09%42.34% (-7.7%)

40% less capital invested

Capital invested by funds: $50.3M → $30.4M (-$19.9M)

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
6
Increased
11
Reduced
10
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ASMB Hedge Fund Activity: Q1 2025 in Review

37 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2025, worth a combined $30.4M — down 40% from $50.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ASMB positions and 4 closed out — a net gain of 2 holders — while 11 added to existing stakes and 10 trimmed.

The largest buyer was B Group Inc, adding an estimated $1.95M. The largest seller was Armistice Capital, cutting an estimated $1.89M.

  • 37 institutional investors held Assembly Biosciences (ASMB) as of Q1 2025, up from 35 in Q4 2024.
  • Funds reported $30.4M of Assembly Biosciences stock for Q1 2025, down 40% quarter-over-quarter.
  • 6 funds opened new Assembly Biosciences positions in Q1 2025 and 4 closed out, a net change of +2 holders.
  • The largest Assembly Biosciences buyer in Q1 2025 was B Group Inc, an estimated $1.95M added.
  • The largest Assembly Biosciences seller in Q1 2025 was Armistice Capital, an estimated $1.89M sold.

Based on aggregated 13F filings for Q1 2025.